Literature DB >> 36172124

Evolution of antibody immunity following Omicron BA.1 breakthrough infection.

Chengzi I Kaku, Tyler N Starr, Panpan Zhou, Haley L Dugan, Paul Khalifé, Ge Song, Elizabeth R Champney, Daniel W Mielcarz, James C Geoghegan, Dennis R Burton, Raiees Andrabi, Jesse D Bloom, Laura M Walker.   

Abstract

Understanding the evolution of antibody immunity following heterologous SAR-CoV-2 breakthrough infection will inform the development of next-generation vaccines. Here, we tracked SARS-CoV-2 receptor binding domain (RBD)-specific antibody responses up to six months following Omicron BA.1 breakthrough infection in mRNA-vaccinated individuals. Cross-reactive serum neutralizing antibody and memory B cell (MBC) responses declined by two- to four-fold through the study period. Breakthrough infection elicited minimal de novo Omicron-specific B cell responses but drove affinity maturation of pre-existing cross-reactive MBCs toward BA.1. Public clones dominated the neutralizing antibody response at both early and late time points, and their escape mutation profiles predicted newly emergent Omicron sublineages. The results demonstrate that heterologous SARS-CoV-2 variant exposure drives the evolution of B cell memory and suggest that convergent neutralizing antibody responses continue to shape viral evolution.

Entities:  

Year:  2022        PMID: 36172124      PMCID: PMC9516849          DOI: 10.1101/2022.09.21.508922

Source DB:  PubMed          Journal:  bioRxiv


  23 in total

Review 1.  Antibody-guided vaccine design: identification of protective epitopes.

Authors:  Antonio Lanzavecchia; Alexander Frühwirth; Laurent Perez; Davide Corti
Journal:  Curr Opin Immunol       Date:  2016-06-22       Impact factor: 7.486

2.  High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method.

Authors:  R Daniel Gietz; Robert H Schiestl
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection.

Authors:  Chengzi I Kaku; Alan J Bergeron; Clas Ahlm; Johan Normark; Mrunal Sakharkar; Mattias N E Forsell; Laura M Walker
Journal:  Sci Immunol       Date:  2022-07-29

4.  Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes.

Authors:  Jasmin Quandt; Alexander Muik; Nadine Salisch; Bonny Gaby Lui; Sebastian Lutz; Kimberly Krüger; Ann-Kathrin Wallisch; Petra Adams-Quack; Maren Bacher; Andrew Finlayson; Orkun Ozhelvaci; Isabel Vogler; Katharina Grikscheit; Sebastian Hoehl; Udo Goetsch; Sandra Ciesek; Özlem Türeci; Ugur Sahin
Journal:  Sci Immunol       Date:  2022-09-16

5.  Prolonged evolution of the human B cell response to SARS-CoV-2 infection.

Authors:  Mrunal Sakharkar; C Garrett Rappazzo; Wendy F Wieland-Alter; Ching-Lin Hsieh; Daniel Wrapp; Emma S Esterman; Chengzi I Kaku; Anna Z Wec; James C Geoghegan; Jason S McLellan; Ruth I Connor; Peter F Wright; Laura M Walker
Journal:  Sci Immunol       Date:  2021-02-23

6.  Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost.

Authors:  Frauke Muecksch; Zijun Wang; Alice Cho; Christian Gaebler; Tarek Ben Tanfous; Justin DaSilva; Eva Bednarski; Victor Ramos; Shuai Zong; Brianna Johnson; Raphael Raspe; Dennis Schaefer-Babajew; Irina Shimeliovich; Mridushi Daga; Kai-Hui Yao; Fabian Schmidt; Katrina G Millard; Martina Turroja; Mila Jankovic; Thiago Y Oliveira; Anna Gazumyan; Marina Caskey; Theodora Hatziioannou; Paul D Bieniasz; Michel C Nussenzweig
Journal:  Nature       Date:  2022-04-21       Impact factor: 69.504

7.  Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants.

Authors:  João Malato; Ruy M Ribeiro; Pedro P Leite; Pedro Casaca; Eugénia Fernandes; Carlos Antunes; Válter R Fonseca; Manuel C Gomes; Luis Graca
Journal:  N Engl J Med       Date:  2022-08-31       Impact factor: 176.079

8.  Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model.

Authors:  Thomas F Rogers; Fangzhu Zhao; Deli Huang; Nathan Beutler; Alison Burns; Wan-Ting He; Oliver Limbo; Chloe Smith; Ge Song; Jordan Woehl; Linlin Yang; Robert K Abbott; Sean Callaghan; Elijah Garcia; Jonathan Hurtado; Mara Parren; Linghang Peng; Sydney Ramirez; James Ricketts; Michael J Ricciardi; Stephen A Rawlings; Nicholas C Wu; Meng Yuan; Davey M Smith; David Nemazee; John R Teijaro; James E Voss; Ian A Wilson; Raiees Andrabi; Bryan Briney; Elise Landais; Devin Sok; Joseph G Jardine; Dennis R Burton
Journal:  Science       Date:  2020-06-15       Impact factor: 47.728

9.  Convergent antibody responses to SARS-CoV-2 in convalescent individuals.

Authors:  Davide F Robbiani; Christian Gaebler; Frauke Muecksch; Julio C C Lorenzi; Zijun Wang; Alice Cho; Marianna Agudelo; Christopher O Barnes; Anna Gazumyan; Shlomo Finkin; Thomas Hägglöf; Thiago Y Oliveira; Charlotte Viant; Arlene Hurley; Hans-Heinrich Hoffmann; Katrina G Millard; Rhonda G Kost; Melissa Cipolla; Kristie Gordon; Filippo Bianchini; Spencer T Chen; Victor Ramos; Roshni Patel; Juan Dizon; Irina Shimeliovich; Pilar Mendoza; Harald Hartweger; Lilian Nogueira; Maggi Pack; Jill Horowitz; Fabian Schmidt; Yiska Weisblum; Eleftherios Michailidis; Alison W Ashbrook; Eric Waltari; John E Pak; Kathryn E Huey-Tubman; Nicholas Koranda; Pauline R Hoffman; Anthony P West; Charles M Rice; Theodora Hatziioannou; Pamela J Bjorkman; Paul D Bieniasz; Marina Caskey; Michel C Nussenzweig
Journal:  Nature       Date:  2020-06-18       Impact factor: 69.504

10.  CoV-AbDab: the coronavirus antibody database.

Authors:  Matthew I J Raybould; Aleksandr Kovaltsuk; Claire Marks; Charlotte M Deane
Journal:  Bioinformatics       Date:  2021-05-05       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.